EPS HEALTH TECH (03860) announced that the Group is expected to record a loss of approximately HK$3 million for the six months ending September 30, 2025 (the Period), compared to a profit of about HK$17.1 million for the same period ending September 30, 2024. The projected loss is primarily attributed to (i) a decrease in fair value gains from acceptance notes related to non-controlling interests, and (ii) reduced government subsidies during the Period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.